Pharmaceutical companies are currently and are likely to remain the dominant end-users of organs-on-chips, because OOC technology offers tremendous potential for predicting side effects and efficacy and
Read MorePharmaceutical companies are currently and are likely to remain the dominant end-users of organs-on-chips, because OOC technology offers tremendous potential for predicting side effects and efficacy and
Read More